Limb splinting for intravenous cannulae in neonates: a randomised controlled trial

被引:19
|
作者
Dalal, S. S. [1 ]
Chawla, D. [2 ]
Singh, J. [1 ]
Agarwal, R. K. [1 ]
Deorari, A. K. [1 ]
Paul, V. K. [1 ]
机构
[1] All India Inst Med Sci, Dept Pediat, Div Neonatol, WHO Collaborating Ctr Newborn Care & Res, New Delhi 110029, India
[2] Govt Med Coll Hosp, Dept Pediat, Chandigarh, India
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 2009年 / 94卷 / 06期
关键词
INTENSIVE-CARE-UNIT;
D O I
10.1136/adc.2008.147595
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To evaluate the efficacy of peripheral intravenous (IV) cannula site joint immobilisation by splint application on functional duration of peripheral IV cannula in neonates. Design: Randomised controlled trial. Setting: Neonatal intensive care unit of a tertiary care hospital. Participants: Neonates requiring continuous IV infusion for an expected duration of more than or equal to 72 hours. Intervention: Eligible cannulations were randomised to either "splint" or "no-splint" group. In the splint group, a cardboard splint was used to immobilise the joint at peripheral IV cannula site. No attempt was made to immobilise the limb in the no-splint group. Outcome measure: Functional duration of a peripheral IV cannula measured as interval from time of insertion to the development of predefined sign of removal (extravasation, blockage, inflammation). Results: A total of 69 peripheral IV cannulations in 54 neonates were randomised to either the splint (n = 33) or no-splint group (n = 36). Both groups were comparable in birth weight, gestation, site of cannulation and nature of fluids administered. Mean functional duration of cannula was lesser in the splint group compared to the no-splint group (h; 23.5 (SD15.9) vs 26.9 (SD15.5), mean difference: -3.3 h, 95% Cl -11.02 to 4.3 h) although the difference was not statistically significant (p = 0.38). Extravasation at cannula site was found be the commonest indication for cannula removal in both the groups (84% vs 76.5%). Conclusion: Joint immobilisation with splint at cannula site did not improve the functional duration of peripheral IV cannula.
引用
收藏
页码:F394 / F396
页数:3
相关论文
共 50 条
  • [21] Intravenous tranexamic acid and lower limb arthroplasty - a randomised controlled feasibility study
    Painter, T. W.
    Daly, D. J.
    Kluger, R.
    Rutherford, A.
    Ditoro, A.
    Grant, C.
    Howell, S.
    ANAESTHESIA AND INTENSIVE CARE, 2018, 46 (04) : 386 - 395
  • [22] A TRIAL OF POVIDONE-IODINE FOR PREVENTION OF CONTAMINATION OF INTRAVENOUS CANNULAE
    JAKOBSEN, CJB
    GRABE, N
    DAMM, MD
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1986, 30 (06) : 447 - 449
  • [23] Upper Limb Rehabilitation After Lung Transplantation: A Randomised Controlled Trial
    Fuller, L. M.
    El-Ansary, D.
    Button, B.
    Corbett, M.
    Snell, G.
    Marasco, S.
    Holland, A. E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S175 - S176
  • [24] Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: double blind randomised controlled trial
    Rainer, TH
    Jacobs, P
    Ng, YC
    Cheung, NK
    Tam, M
    Lam, PKW
    Wong, R
    Cocks, RA
    BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7271): : 1247 - 1251
  • [25] A randomised controlled trial of perineural vs intravenous dexamethasone for foot surgery
    Dawson, R. L.
    McLeod, D. H.
    Koerber, J. P.
    Plummer, J. L.
    Dracopoulos, G. C.
    ANAESTHESIA, 2016, 71 (03) : 285 - 290
  • [26] Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial
    Lees, KR
    Muir, KW
    Ford, I
    Reid, JL
    Mendelow, AD
    Sandercock, PAG
    Bath, PMW
    Lees, KR
    Ford, I
    Muir, KW
    Lees, KR
    Bath, PMW
    Chen, C
    Davis, SM
    Muir, KW
    Phillips, SJ
    Saver, J
    Vanhooren, G
    Forbes, C
    Murray, G
    Bone, I
    Ford, I
    Norrie, J
    Kean, S
    Robertson, M
    Murray, H
    McIlvenna, Y
    Gardner, A
    Bradford, A
    Fenton, J
    Sakhri, A
    Rodger, M
    Sanmuganathan, P
    Milia, P
    Chong, V
    Teasdale, E
    Muir, KW
    Lees, KR
    Ford, I
    Davis, S
    Donnan, G
    Crimmins, D
    Hankey, G
    Vanhooren, G
    Phillips, S
    Shuaib, A
    Bailey, P
    Jaramillo, A
    Lisheng, L
    Li, KB
    LANCET, 2004, 363 (9407): : 439 - 445
  • [27] Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
    Santer, Peter
    McGahey, Anne
    Frise, Matthew C.
    Petousi, Nayia
    Talbot, Nick P.
    Baskerville, Richard
    Bafadhel, Mona
    Nickol, Annabel H.
    Robbins, Peter A.
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [28] Efficacy of pulse intravenous methylprednisolone in epileptic encephalopathy: a randomised controlled trial
    Rangarajan, Anush
    Mundlamuri, Ravindranadh Chowdary
    Kenchaiah, Raghavendra
    Prathyusha, Parthipulli Vasuki
    Viswanathan, Lakshminarayanapuram Gopal
    Asranna, Ajay
    Chatterjee, Aparajita
    Nagappa, Madhu
    Seshagiri, Doniparthi Venkata
    Kulanthaivelu, Karthik
    Bharath, Rose Dawn
    Jitender, Saini
    Thennarasu, Kandavel
    Sinha, Sanjib
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (12): : 1299 - 1305
  • [29] Entonox is superior to intravenous sedation: Proof from randomised controlled trial
    Maslekar, S
    Hughes, M
    Skinn, E
    Gardiner, A
    Culbert, B
    Duthie, GS
    GUT, 2006, 55 : A4 - A4
  • [30] Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
    Hill, Matilda
    Iro, Mildred
    Sadarangani, Manish
    Absoud, Michael
    Cantrell, Liberty
    Chong, Kling
    Clark, Christopher
    Easton, Ava
    Gray, Victoria
    Kneen, Rachel
    Lim, Ming
    Liu, Xinxue
    Pike, Michael
    Solomon, Tom
    Vincent, Angela
    Willis, Louise
    Yu, Ly-Mee
    Pollard, Andrew J.
    BMJ OPEN, 2023, 13 (11):